Katelyn Patterson - In Practice

Real Clinics. Real Patients. Real Oncology.

Home

/ Authors /

Katelyn Patterson

Katelyn Patterson

,

PharmD

Pharmacist

Henry Ford Hospital, Detroit, MI

From this Author

Clinical Trials

Characterization of A Dose-Dense Doxorubicin and Cyclophosphamide Regimen for Triple-Negative Breast Cancer Within the KEYNOTE-522 Trial

Characterization of A Dose-Dense Doxorubicin and Cyclophosphamide Regimen for Triple-Negative Breast Cancer Within the KEYNOTE-522 Trial

Samantha Hodges, PharmD; Katelyn Patterson, PharmD, et al.

September 8, 2026

Oncology is evolving. Stay current.

Weekly breakthroughs, expert insights, and clinical updates —delivered to your inbox.